Figure 1.
Development of a new site of disease in patients with oligometastatic NSCLC who do not progress on front-line systemic therapy. NSCLC, non-small cell lung cancer.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.